Secondary analysis of the RECOVER trial of adjunctive active vs sham vagus nerve stimulation in markedly treatment-resistant depression: MADRS, QIDS-C and QIDS-SR were reliable and unidimensional, but MADRS totals were less sensitive to change.
Secondary analysis
Rush et al. Assessing symptom severity in patients with markedly treatment-resistant depression: Insights from the RECOVER trial